{"TopicDetails": {"type": 0, "ccm2Id": 45032627, "cftId": 0, "identifier": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04", "title": "Creating a sustainable clinical trial network for infectious diseases in sub-Saharan Africa", "publicationDateLong": 1652227200000, "callIdentifier": "HORIZON-JU-GH-EDCTP3-2022-01", "callTitle": "Research and Innovation actions supporting the global health EDCTP3 Joint Undertaking", "callccm2Id": 45032759, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "topicMGAs": [], "tags": ["infectious diseases", "emerging infectious disease", "preparedness for epidemics", "vaccines", "clinical trial network", "clinical trials platform", "sub-Saharan Africa", "clinical trial infrastructure", "global health", "Africa"], "keywords": ["Africa", "Prevention and treatment of infection by pathogens", "Clinical trials", "Global health", "Poverty related diseases", "Public and environmental health", "Clinical data", "Emerging Epidemics", "Public health", "Infectious diseases", "International Cooperation", "Social sciences and humanities", "Clinical targets", "Neglected Infectious Diseases"], "flags": ["Africa", "EC-WORLD", "SSH"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "HORIZON-JU-CSA HORIZON JU Coordination and Support Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "11 May 2022", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["30 August 2022"]}], "latestInfos": [{"approvalDate": "Oct 7, 2022 10:57:19 AM", "lastChangeDate": "Oct 7, 2022 10:57:19 AM", "content": "<p><span lang=\"EN-IE\" style=\"font-size: 10.5pt; line-height: 107%; font-family: &quot;inherit&quot;, serif; color: rgb(51, 51, 51); border: 1pt none windowtext; padding: 0cm;\">Call </span><span lang=\"EN-IE\">HORIZON-JU-GH-EDCTP3-2022-01</span><span lang=\"EN-IE\" style=\"font-size: 10.5pt; line-height: 107%; font-family: &quot;inherit&quot;, serif; color: rgb(51, 51, 51); border: 1pt none windowtext; padding: 0cm;\"> closed on 30 August 2022. A total of 92 proposals were submitted. The breakdown per topic is:</span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01: 40 proposals&nbsp;</span><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&#10;&quot;inherit&quot;,serif;mso-bidi-font-family:Calibri;color:#333333;border:none windowtext 1.0pt;&#10;mso-border-alt:none windowtext 0cm;padding:0cm;mso-ansi-language:EN-IE;&#10;mso-fareast-language:FR-BE\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02: 14 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03: 20 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04:&nbsp; 2 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 3.75pt 18.75pt; text-indent: -18pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><!--[if !supportLists]--><span lang=\"EN-IE\" style=\"font-size:10.0pt;mso-bidi-font-size:10.5pt;font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">&middot;<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]--><span lang=\"EN-IE\" style=\"font-size:10.5pt;font-family:&quot;inherit&quot;,serif;color:#333333;&#10;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;padding:0cm;&#10;mso-ansi-language:EN-IE;mso-fareast-language:FR-BE\">HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05: 16 proposals<o:p></o:p></span></p>\r\n<p><span lang=\"EN-IE\" style=\"font-size:10.5pt;line-height:107%;font-family:&quot;inherit&quot;,serif;&#10;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:&#10;&quot;Times New Roman&quot;;mso-bidi-theme-font:minor-bidi;color:#333333;border:none windowtext 1.0pt;&#10;mso-border-alt:none windowtext 0cm;padding:0cm;mso-ansi-language:EN-IE;&#10;mso-fareast-language:FR-BE;mso-bidi-language:AR-SA\">Evaluation results are expected to be communicated on Friday 21 November 2022 at the earliest.</span></p>"}], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3418887": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05 - HORIZON-JU-CSA HORIZON JU Coordination and Support Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 5000000}, "expectedGrants": 8, "minContribution": 600000, "maxContribution": 600000, "budgetTopicActionMap": {}}], "3418889": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04 - HORIZON-JU-CSA HORIZON JU Coordination and Support Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 1000000}, "expectedGrants": 1, "minContribution": 1000000, "maxContribution": 1000000, "budgetTopicActionMap": {}}], "3418891": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02 - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 30850000}, "expectedGrants": 5, "minContribution": 6000000, "maxContribution": 8000000, "budgetTopicActionMap": {}}], "3418893": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03 - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 22000000}, "expectedGrants": 4, "minContribution": 5000000, "maxContribution": 5000000, "budgetTopicActionMap": {}}], "3418895": [{"action": "HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01 - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "11 May 2022", "deadlineModel": "single-stage", "deadlineDates": ["30 August 2022"], "budgetYearMap": {"2022": 38030000}, "expectedGrants": 9, "minContribution": 4000000, "maxContribution": 4000000, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2022"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p>This topic aims at supporting activities that are contributing to one or several of the expected impacts for this call. To that end, proposals under this topic should aim for delivering results that are directed towards and contributing to the following expected outcomes:</p><ul level=\"0\"><li>A well-documented overview of operational and effective regional clinical trial and laboratory networks in different clinical settings in sub-Saharan Africa, and the existing coordination mechanisms within and between the networks, is developed;</li><li>An efficient coordination and collaboration mechanism between identified clinical trial and laboratory networks in sub-Saharan Africa is established and sustained;</li><li>The foundation for a coordinated, permanent, pan sub-Saharan African clinical trial infrastructure to optimise a coordinated response to infectious diseases threats, including emerging infections, is laid, taking advantage of the existing EDCTP\u2019s Networks of Excellence;</li><li>The role of Africa in clinical research preparedness for future epidemics and pandemics is strengthened.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>The work carried out under this topic should lay the foundation for the establishment of a pan sub-Saharan African infrastructure of clinical trial facilities that continuously evaluate health interventions (incl. vaccines, treatments and diagnostics) for infectious diseases in a coordinated, harmonized manner to maximize trial efficiency. Such an infrastructure should leverage the work done by EDCTP Networks of Excellence<sup><a target=_self href=#fn1 id=r1>[1]</a></sup> through interaction with these networks. It should also be capable of quickly and easily adapting ongoing clinical trials for vaccines, treatments or diagnostics to tackle emerging infectious disease threats, if and when the need arises.</p><p>The purpose of this topic is to support one project which will carry out a desk review and mapping exercise of the current landscape of clinical trial and laboratory networks in sub-Saharan Africa. Such an exercise would provide the basis for the creation of the intended network. The network could be composed of regional networks in Sub-Saharan Africa, each regional network with its connected clinical trial sites and laboratories. The structure to be built needs to ensure a harmonised approach to clinical trial implementation.</p><p>Relevant regional and international organisations, such as the World Health Organization - Regional Office for Africa, the African Medicines Agency (AMA) or the Africa Centre for Disease Control and Prevention (Africa CDC), should be consulted when developing the plans for the future network.</p><p>Proposals should address the following areas:</p><ul level=\"0\"><li>Conducting a mapping exercise to analyse the operational and effective clinical trial and laboratory networks in different clinical settings in sub-Saharan Africa, including their related coordination mechanisms;</li><li>Establishing a clinical trial network, possibly composed of sub-networks in sub-Saharan Africa, under which the clinical sites and laboratories will collaborate and coordinate their activities. The network(s) should work in close collaboration EDCTP\u2019s Networks of Excellence<sup><a target=_self href=#fn2 id=r2>[2]</a></sup> and take into account the work and operational network infrastructure established by the Networks of Excellence;</li><li>Planning for common preparedness research approaches and tools within the network(s), such as clinical trial protocols including master protocols, as well as a comprehensive data management framework allowing the collection, storage, analysis and sharing of standardised data between relevant clinical sites and laboratories;</li><li>Developing an electronic registry of trial sites and laboratories, covering relevant information on their capacity to implement clinical trials, as a tool to enable large-scale trials;</li><li>Establishing a strong coordination and collaboration mechanism to support the harmonization of clinical trials across the sub-Saharan African infrastructure of clinical trial facilities;</li><li>Coordinating and collaborating with relevant other initiatives including those funded by previous EDCTP programmes such as the epidemic preparedness and response research networks ALERRT<sup><a target=_self href=#fn3 id=r3>[3]</a></sup> and PANDORA<sup><a target=_self href=#fn4 id=r4>[4]</a></sup>, to avoid duplication of activities and ensure complementarity;</li><li>Developing a business plan for operationalising the pan sub-Saharan infrastructure of clinical trial facilities that continuously evaluate health interventions (incl. vaccines, treatments and diagnostics) for infectious diseases in sub-Saharan Africa and which, in case of a health threat, are able to quickly and easily adapt to tackle such threat;</li><li>This business plan should be developed through consultation with relevant African stakeholders, such as representatives from regulatory authorities, industry, policy makers, patient organisations, etc., as well as relevant European trial coordinators and stakeholders;</li><li>Promoting the visibility and attractiveness of the future infrastructure for investigators and sponsors of clinical trials in infectious diseases; as well as active communication with the science community, patient advocacy groups and other stakeholders.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=Africa;sortQuery=sortStatus;orderBy=asc\">Africa</a><br><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=43108390;crossCuttingPriorityCode=EC-WORLD;sortQuery=sortStatus;orderBy=asc\">International Cooperation</a><br>Social sciences and humanities<br></p>\n<p id=fn1><a  target=_self href=#r1>[1]</a>https://www.edctp.org/our-work/edctp-regional-networks-of-excellence/</p><p id=fn2><a  target=_self href=#r2>[2]</a><a href=\"http://www.edctp.org/our-work/edctp-regional-networks-of-excellence/\">http://www.edctp.org/our-work/edctp-regional-networks-of-excellence/</a></p><p id=fn3><a  target=_self href=#r3>[3]</a><a href=\"https://www.alerrt.global/\">https://www.alerrt.global/</a></p><p id=fn4><a  target=_self href=#r4>[4]</a><a href=\"https://www.pandora-id.net/\">https://www.pandora-id.net/</a></p>", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:11.0pt;line-height:115%;&#10;font-family:&quot;Calibri&quot;,sans-serif;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:&#10;Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;&#10;mso-bidi-font-family:&quot;Times New Roman&quot;;mso-bidi-theme-font:minor-bidi;&#10;color:#404040;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:EN-US;&#10;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\">General conditions</span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">1. Admissibility conditions: </span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;&#10;mso-bidi-font-weight:bold\">described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex A</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> and </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex E</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> of the Horizon Europe Work Programme General Annexes</span></p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\" style=\"mso-ansi-language:&#10;EN-US\"> described in Part B of the Application Form available in the Submission System</span></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b></p>\r\n<p><span lang=\"EN-US\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">According to Article 110 of the Council Regulation (EU) 2021/2085, funding from the&nbsp; Global Health EDCTP3 Joint Undertaking is restricted to legal entities established in Member States or associated countries or in the constituent states of the EDCTP Association.</span></p>\r\n<p><span lang=\"EN-US\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">Constituent states of the EDCTP Association that are not Member States or associated countries are: Burkina Faso, Cameroon, Congo, C&ocirc;te d&rsquo;Ivoire, Ethiopia, Gabon, The Gambia, Ghana,&nbsp;</span><span style=\"font-family: Calibri, sans-serif; font-size: 14.6667px;\">Kenya,</span><span style=\"font-family: Calibri, sans-serif; font-size: 14.6667px;\">&nbsp;</span><span style=\"font-family: Calibri, sans-serif; font-size: 11pt;\">Mali, Mozambique, Niger, Nigeria, Senegal, South Africa, Tanzania, Uganda, United Kingdom, Zambia.</span></p>\r\n<p><span lang=\"EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the&nbsp;</span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\">Horizon Europe Programme Guide</a></span><span lang=\"EN-US\">.</span></p>\r\n<p>&nbsp;</p>\n<p>&nbsp;<b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in&nbsp;</span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex B</a></span>&nbsp;<span lang=\"EN-US\">of the Work Programme General Annexes,&nbsp;</span>except for the specific conditions for GH EDCTP3 funding as regards&nbsp;<u>Entities eligible for funding</u>&nbsp;and&nbsp;<u>Consortium composition.</u></p>\r\n<p class=\"MsoNormal\"><i><u><span lang=\"EN-IE\">Entities eligible to participate<o:p></o:p></span></u></i></p>\r\n<p class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-IE\">Given the illegal invasion of Ukraine by Russia and the involvement of Belarus, there is currently no appropriate context allowing the implementation of the actions foreseen in this programme with legal entities established in Russia, Belarus, or in non-government controlled territories of Ukraine. Therefore, such legal entities are not eligible to participate in any capacity. This criterion also applies in cases where the action involves financial support given by grant beneficiaries to third parties established in Russia, Belarus or in non-government controlled territories of Ukraine (in accordance with Article 204 of the Financial Regulation No 2018/1046).<b><u><o:p></o:p></u></b></span></p>\r\n<p class=\"MsoNormal\"><i><u><span lang=\"EN-IE\">Entities eligible for funding<o:p></o:p></span></u></i></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-IE\">To be eligible for funding, applicants must be eligible to participate and established in one of the eligible countries, i.e.<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\">-<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">The Member States of the European Union, including their outermost regions;<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\">-<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">The Oversees Countries and Territories (OCTs) linked to Member States<a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftn1\" name=\"_ftnref1\" title=\"\"><span class=\"MsoFootnoteReference\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">[1]</span></span></span></a><o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\">-<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">Eligible non-EU countries:<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left: 72pt; text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\" style=\"font-family: &quot;Courier New&quot;;\">o<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">Countries associated to Horizon Europe<a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftn2\" name=\"_ftnref2\" title=\"\"><span class=\"MsoFootnoteReference\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">[2]</span></span></span></a><o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left: 72pt; text-indent: -18pt; line-height: 12.6px;\"><span lang=\"EN-IE\" style=\"font-family: &quot;Courier New&quot;;\">o<span style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;\">&nbsp;&nbsp;&nbsp;</span></span><span lang=\"EN-IE\">Countries that are members of the EDCTP Association<a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftn3\" name=\"_ftnref3\" title=\"\"><span class=\"MsoFootnoteReference\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">[3]</span></span></span></a><o:p></o:p></span></p>\r\n<p><span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">Legal entities which are established in countries not listed above will be eligible for funding if provided for in the specific call conditions, or if the participation is considered essential for implementing the action by the granting authority.</span></p>\r\n<div><br clear=\"all\" />\r\n<hr align=\"left\" size=\"1\" width=\"33%\" />\r\n<div id=\"ftn1\">\r\n<p class=\"MsoFootnoteText\"><a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftnref1\" name=\"_ftn1\" title=\"\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 14.2667px; font-family: Calibri, sans-serif;\">[1]</span></span></span></span></a><span lang=\"EN-US\">&nbsp;</span><span lang=\"EN-IE\">Entities from Oversees Countries and Territories (OCT) are eligible for funding under the same conditions as entities from the Member State to which the OCT in question is linked. See the&nbsp;</span><span lang=\"EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span lang=\"EN-IE\">Horizon Europe Programme Guide</span></a></span><span lang=\"EN-IE\">&nbsp;for a complete list of OCTs.</span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n</div>\r\n<div id=\"ftn2\">\r\n<p class=\"MsoFootnoteText\"><a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftnref2\" name=\"_ftn2\" title=\"\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 14.2667px; font-family: Calibri, sans-serif;\">[2]</span></span></span></span></a><span lang=\"EN-US\">&nbsp;</span><span lang=\"EN-IE\">See list of&nbsp;</span><span lang=\"EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/list-3rd-country-participation_horizon-euratom_en.pdf\"><span lang=\"EN-IE\">associated countries</span></a></span><span class=\"MsoHyperlink\"><span lang=\"EN-IE\">&nbsp;and&nbsp;<a href=\"https://ec.europa.eu/info/research-and-innovation/strategy/strategy-2020-2024/europe-world/international-cooperation_en\" target=\"_blank\">International Cooperation</a></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n</div>\r\n<div id=\"ftn3\">\r\n<p class=\"MsoFootnoteText\"><a href=\"file:///C:/Users/crisaal/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/32LODOYY/Topic%20Conditions%20new.docx#_ftnref3\" name=\"_ftn3\" title=\"\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\"><span class=\"MsoFootnoteReference\"><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 14.2667px; font-family: Calibri, sans-serif;\">[3]</span></span></span></span></a><span lang=\"EN-US\">&nbsp;</span><span lang=\"EN-IE\">See the&nbsp;</span><span lang=\"EN-US\"><a href=\"http://www.edctp.org/about-us/governance/general-assembly/members-of-the-general-assembly/\"><span lang=\"EN-IE\">EDCTP website</span></a></span></p>\r\n</div>\r\n</div>\r\n<p>&nbsp;</p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b>4. Financial and operational capacity and exclusion: </b><span style=\"mso-bidi-font-weight:bold\">described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex C</a> of the Work Programme General Annexes</span></p>\r\n<p>&nbsp;</p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"FR-BE\" style=\"mso-ansi-language:FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\r\n<p>&nbsp;</p>\n<div>\r\n<ul type=\"square\" style=\"margin-top: 0cm;\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Award criteria&nbsp;</span></b><span lang=\"EN-US\">&nbsp;are described in&nbsp;</span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex D</a></span><span lang=\"EN-US\">&nbsp;of the Work Programme General Annexes.</span></li>\r\n    <li class=\"MsoNormal\">\r\n    <p class=\"MsoNormal\"><strong><span lang=\"EN-US\">Scoring and thresholds</span></strong><span lang=\"EN-US\">&nbsp;are as follows:<o:p></o:p></span></p>\r\n    <p class=\"MsoNormal\" style=\"text-align: justify;\"><span lang=\"EN-IE\">Evaluation scores will be awarded for the criteria, and not for the different aspects listed in the table. For full applications, each criterion will be scored out of 5. The threshold for individual criteria 1 (Excellence) and 2 (Impact) will be 4 and for criteria 3 (Quality and efficiency of the implementation) will be 3. The overall threshold, applying to the sum of the three individual scores, will be 12.<o:p></o:p></span></p>\r\n    <span lang=\"EN-IE\" style=\"font-size: 11pt; line-height: 15.6933px; font-family: Calibri, sans-serif;\">Proposals that pass the individual threshold AND the overall threshold will be considered for funding, within the limits of the available call budget. Other proposals will be rejected.</span></li>\r\n</ul>\r\n</div>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex      F</a></span><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\">Online      Manual</a><span lang=\"EN-US\"><o:p></o:p></span></li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex      F</a></span><span lang=\"EN-US\"> of the Work Programme General Annexes</span><span lang=\"EN-US\"><o:p></o:p></span></li>\r\n</ul>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">described in </span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\">Annex G</a></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"> of the Work Programme General Annexes<o:p></o:p></span></p>\r\n<p>&nbsp;</p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\">Specific conditions<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\">7. Specific conditions: </span></b><span lang=\"EN-US\">described in the specific topic of the Work Programme<o:p></o:p></span></p>\n<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\">Documents<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">Call documents:<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:bold\">Standard application form &mdash;<i style=\"mso-bidi-font-style:normal\"> call-specific application form is available in the Submission System</i><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-csa_en.pdf\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\">Standard application form (HE CSA)</span></a><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><o:p></o:p></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Standard evaluation form </span><span lang=\"EN-US\">&mdash;<i> will be used with the necessary adaptations</i></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/ef/ef_he-csa_en.pdf\"><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:bold\">Standard evaluation form (HE CSA)</span></a><span lang=\"EN-US\" style=\"color:#404040;&#10;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> <o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\">&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US;mso-bidi-font-weight:bold\">MGA</span><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:&#10;191.4pt\"><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\">HE <span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">General MGA v1.1</span></a></span></span><span class=\"MsoHyperlink\"><span style=\"mso-ansi-language:EN-US;mso-bidi-font-weight:&#10;bold\"> <span lang=\"EN-US\"><o:p></o:p></span></span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\">Additional documents:</span></b></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/sites/default/files/research_and_innovation/research_by_area/documents/ec_rtd_global-health-edctp3-wp-annex1.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">GH EDCTP3 JU Work Programme 2022</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><b><span lang=\"EN-US\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Main Work Programme 2021&ndash;2022 &ndash; 13. General Annexes</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\"><span lang=\"EN-US\">EU Grants AGA&nbsp;</span>&mdash; Annotated Model Grant Agreement</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">&nbsp;&nbsp;</p>\r\n<ul style=\"padding: 0px; margin: 3px 0px 3px 30px; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2021.427.01.0017.01.ENG&amp;toc=OJ%3AL%3A2021%3A427%3ATOC\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">GH EDCTP3 JU Regulation of Establishment</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Programme guide</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Framework Programme and rules for Participation Regulation&nbsp; 2021/695</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">HE Specific Programme Decision 2021/764</a></li>\r\n    <li style=\"padding: 0px; margin: 0px; color: rgb(51, 51, 51); line-height: 1.4; list-style-type: square;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">EU Financial Regulation</a></li>\r\n</ul>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\">Funding &amp; Tenders Portal Terms and Conditions</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size:11.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;&#10;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:&#10;minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:&quot;Times New Roman&quot;;&#10;mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB;mso-fareast-language:&#10;EN-US;mso-bidi-language:AR-SA\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\">Funding &amp; Tenders Portal Privacy Statement</a></span></p>", "supportInfo": "<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><b>Online Manual&nbsp;</b></a></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span></p>\r\n<p><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" target=\"_blank\">National Contact Points (NCPs)</a>&nbsp;</span></b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (&lsquo;third-countries&rsquo;).<b><o:p></o:p></b></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><strong><u><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span></u></strong><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "", "staticAdditionalInfo": "<p>The general conditions relating to this call are those applicable to the 2021/2022 work programme of Global Health EDCTP3 outlined above.</p><p><u>Expected impacts of Call 1</u></p><p>Activities funded under this call for proposals should contribute to:</p><ul level=\"0\"><li>Achieve SDG3 \u2018Ensure healthy lives and promote well-being for all at all ages\u2019 in sub-Saharan African countries;</li><li>Provide evidence for informed health policies and guidelines within public health systems in sub-Saharan Africa and at international level;</li><li>Strengthen clinical research capability in sub-Saharan Africa to rapidly respond to emerging epidemics;</li><li>Enable a regulatory environment that can ensure effective development, delivery, and uptake of new or improved safe health technologies guaranteeing that trials in sub-Saharan African countries meet international standards;</li><li>Enable countries in sub-Saharan Africa to better understand pathogen epidemiology and support effective public health monitoring through integration of genomics and epidemiology;</li><li>Increase cost effectiveness of public investment through collaboration of funders of clinical trials in the area of infectious diseases in sub-Saharan Africa;</li><li>Strengthen health systems to ensure uptake of effective health technologies and innovations;</li><li>Enhance sustainable global scientific collaboration in health research and international cooperation across sub-Saharan Africa.</li> </ul>\n", "latestInfos": [{"approvalDate": "Dec 22, 2022 8:21:02 AM", "lastChangeDate": "Dec 22, 2022 8:21:02 AM", "content": "<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Information for the Funding Portal<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number proposals submitted: 92<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number Ineligible proposals: 11<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number proposals evaluated: 81<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Below threshold: 36<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Above threshold: 45<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Main list: 26<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number of Reserve list: 4<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - Number rejected due to budgetary ressources: 15<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-size:12.0pt;line-height:107%;mso-ansi-language:EN-IE\">Number of proposal upgraded from Reserve list to Main list: 1</span></b><span lang=\"EN-IE\"><o:p></o:p></span></p>"}, {"approvalDate": "May 17, 2022 4:30:46 PM", "lastChangeDate": "May 17, 2022 4:30:46 PM", "content": "The submission session is now available for: HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01(HORIZON-JU-RIA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04(HORIZON-JU-CSA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03(HORIZON-JU-RIA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02(HORIZON-JU-RIA), HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05(HORIZON-JU-CSA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}